- Registration approval of NURTEC ODT in Kuwait is third in Middle East region, joining prior market approvals in Israel and United Arab Emirates
- NURTEC ODT is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist available in a fast-acting orally disintegrating tablet (ODT)
- A single oral dose of NURTEC ODT 75 mg can provide fast pain relief and return patients to normal function within 60 minutes, and deliver sustained efficacy that lasts up to 2 days for many patients
PR Newswire
NEW HAVEN, Conn., Nov. 17, 2021